These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17643115)

  • 1. A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.
    Katz M; Amit I; Citri A; Shay T; Carvalho S; Lavi S; Milanezi F; Lyass L; Amariglio N; Jacob-Hirsch J; Ben-Chetrit N; Tarcic G; Lindzen M; Avraham R; Liao YC; Trusk P; Lyass A; Rechavi G; Spector NL; Lo SH; Schmitt F; Bacus SS; Yarden Y
    Nat Cell Biol; 2007 Aug; 9(8):961-9. PubMed ID: 17643115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tensins: a new switch in cell migration.
    Mouneimne G; Brugge JS
    Dev Cell; 2007 Sep; 13(3):317-9. PubMed ID: 17765673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.
    Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V
    Cancer Res; 2010 Mar; 70(6):2558-67. PubMed ID: 20215508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple pathways regulate Cten in colorectal cancer without a Tensin switch.
    Thorpe H; Akhlaq M; Jackson D; Al Ghamdi S; Storr S; Martin S; Ilyas M
    Int J Exp Pathol; 2015 Dec; 96(6):362-9. PubMed ID: 26852686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator of transcription 3.
    Bennett DT; Reece TB; Foley LS; Sjoberg A; Meng X; Fullerton DA; Weyant MJ
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):369-75. PubMed ID: 25439778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis.
    Albasri A; Aleskandarany M; Benhasouna A; Powe DG; Ellis IO; Ilyas M; Green AR
    Breast Cancer Res Treat; 2011 Feb; 126(1):47-54. PubMed ID: 20390342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.
    Hong SY; Shih YP; Li T; Carraway KL; Lo SH
    Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer.
    Al-Ghamdi S; Cachat J; Albasri A; Ahmed M; Jackson D; Zaitoun A; Guppy N; Otto WR; Alison MR; Kindle KB; Ilyas M
    Pancreas; 2013 Jan; 42(1):135-40. PubMed ID: 22750970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal tensin-like (CTEN): a promising biomarker and target for cancer.
    Lo SH
    Int J Biochem Cell Biol; 2014 Jun; 51():150-4. PubMed ID: 24735711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.
    Lo SH; Lo TB
    Cancer Res; 2002 Aug; 62(15):4217-21. PubMed ID: 12154022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer.
    Li Y; Mizokami A; Izumi K; Narimoto K; Shima T; Zhang J; Dai J; Keller ET; Namiki M
    Prostate; 2010 Jan; 70(1):48-60. PubMed ID: 19725034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma.
    Chan LK; Chiu YT; Sze KM; Ng IO
    Oncotarget; 2015 Aug; 6(25):20964-76. PubMed ID: 26035355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer.
    Albasri A; Seth R; Jackson D; Benhasouna A; Crook S; Nateri AS; Chapman R; Ilyas M
    J Pathol; 2009 May; 218(1):57-65. PubMed ID: 19214987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
    Cao X; Voss C; Zhao B; Kaneko T; Li SS
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3.
    Cui Y; Liao YC; Lo SH
    Mol Cancer Res; 2004 Apr; 2(4):225-32. PubMed ID: 15140944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ΔNp63α Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion.
    Yang K; Wu WM; Chen YC; Lo SH; Liao YC
    PLoS One; 2016; 11(1):e0147542. PubMed ID: 26784942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tensin relief facilitates migration.
    Pylayeva Y; Giancotti FG
    Nat Cell Biol; 2007 Aug; 9(8):877-9. PubMed ID: 17671456
    [No Abstract]   [Full Text] [Related]  

  • 18. Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer.
    Albasri A; Al-Ghamdi S; Fadhil W; Aleskandarany M; Liao YC; Jackson D; Lobo DN; Lo SH; Kumari R; Durrant L; Watson S; Kindle KB; Ilyas M
    Oncogene; 2011 Jun; 30(26):2997-3002. PubMed ID: 21339732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of C-Terminal Tensin-Like Protein (CTEN) Suppresses Prostate Cell Proliferation and Contributes to Acinar Morphogenesis.
    Wu WM; Liao YC
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer.
    Lu X; Zhou B; Cao M; Shao Q; Pan Y; Zhao T
    Technol Cancer Res Treat; 2021; 20():15330338211045506. PubMed ID: 34817293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.